Introducing the PhotonUVC
Novel first-line treatment for Corneal Infections.
The non-contact, 15-second treatment from the patented PhotonUVC emits low dose UVC light at a targeted area, deactivating infecting organisms while being safe to host tissues.
Photon Therapeutics draws on the expertise of pioneers in ophthalmic research and clinical science.
Address86-90 Paul Street